136 related articles for article (PubMed ID: 32435931)
1. The value of the black fiber sign on T1-weighted images for predicting stability of desmoid fibromatosis managed conservatively.
Murahashi Y; Emori M; Shimizu J; Anzai K; Tanaka T; Naka N; Tsuchie H; Nagasawa H; Miyakoshi N; Shimada Y; Yamashita T
Eur Radiol; 2020 Oct; 30(10):5768-5776. PubMed ID: 32435931
[TBL] [Abstract][Full Text] [Related]
2. Evidence-based MR imaging follow-up strategy for desmoid-type fibromatosis.
Gondim Teixeira PA; Biouichi H; Abou Arab W; Rios M; Sirveaux F; Hossu G; Blum A
Eur Radiol; 2020 Feb; 30(2):895-902. PubMed ID: 31468156
[TBL] [Abstract][Full Text] [Related]
3. Correlation between tumor growth and hormonal therapy with MR signal characteristics of desmoid-type fibromatosis: A preliminary study.
Gondim Teixeira PA; Chanson A; Verhaeghe JL; Lecocq S; Louis M; Hossu G; Blum A
Diagn Interv Imaging; 2019 Jan; 100(1):47-55. PubMed ID: 30037746
[TBL] [Abstract][Full Text] [Related]
4. What is the best front-line approach in patients with desmoid fibromatosis? - A retrospective analysis from a reference center.
Sobczuk P; Agnieszczak IM; Grycuk W; Czarnecka AM; Świtaj T; Koseła-Paterczyk H; Morysiński T; Zdzienicki M; Rutkowski P
Eur J Surg Oncol; 2021 Oct; 47(10):2602-2608. PubMed ID: 33994241
[TBL] [Abstract][Full Text] [Related]
5. Association of MRI T2 Signal Intensity With Desmoid Tumor Progression During Active Observation: A Retrospective Cohort Study.
Cassidy MR; Lefkowitz RA; Long N; Qin LX; Kirane A; Sbaity E; Hameed M; Coit DG; Brennan MF; Singer S; Crago AM
Ann Surg; 2020 Apr; 271(4):748-755. PubMed ID: 30418203
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging patterns of tumor response to chemotherapy in desmoid-type fibromatosis.
Zanchetta E; Ciniselli CM; Bardelli A; Colombo C; Stacchiotti S; Baldi GG; Provenzano S; Bertulli R; Bini F; Casale A; Greco FG; Ferrari A; Verderio P; Fiore M; Gronchi A; Casali PG; Morosi C; Palassini E
Cancer Med; 2021 Jul; 10(13):4356-4365. PubMed ID: 34102009
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of pretreatment MRI texture analysis in patients with primary nasopharyngeal carcinoma.
Mao J; Fang J; Duan X; Yang Z; Cao M; Zhang F; Lu L; Zhang X; Wu X; Ding Y; Shen J
Eur Radiol; 2019 Aug; 29(8):4105-4113. PubMed ID: 30617473
[TBL] [Abstract][Full Text] [Related]
8. Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI.
Ingley KM; Burtenshaw SM; Theobalds NC; White LM; Blackstein ME; Gladdy RA; Thipphavong S; Gupta AA
Cancer Med; 2019 Sep; 8(11):5047-5057. PubMed ID: 31301110
[TBL] [Abstract][Full Text] [Related]
9. Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma Group.
Crombé A; Kind M; Ray-Coquard I; Isambert N; Chevreau C; André T; Lebbe C; Cesne AL; Bompas E; Piperno-Neumann S; Saada E; Bouhamama A; Blay JY; Italiano A;
AJR Am J Roentgenol; 2020 Dec; 215(6):1539-1548. PubMed ID: 32991215
[No Abstract] [Full Text] [Related]
10. Efficacy and safety of apatinib for patients with advanced extremity desmoid fibromatosis: a retrospective study.
Zheng C; Fang J; Wang Y; Zhou Y; Tu C; Min L
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2127-2135. PubMed ID: 33452581
[TBL] [Abstract][Full Text] [Related]
11. The Activity and Safety of Anlotinib for Patients with Extremity Desmoid Fibromatosis: A Retrospective Study in a Single Institution.
Zheng C; Zhou Y; Wang Y; Luo Y; Tu C; Min L
Drug Des Devel Ther; 2020; 14():3941-3950. PubMed ID: 33061299
[TBL] [Abstract][Full Text] [Related]
12. [Imaging manifestations and pathologic features of soft tissue desmoid-type fibromatosis].
Liu QY; Chen JY; Liang BL; Li HG; Gao M; Lin XF
Ai Zheng; 2008 Dec; 27(12):1287-92. PubMed ID: 19079995
[TBL] [Abstract][Full Text] [Related]
13. Desmoid-type fibromatosis-associated Gardner fibromas: prevalence and impact on local recurrence.
Cates JM; Stricker TP; Sturgeon D; Coffin CM
Cancer Lett; 2014 Oct; 353(2):176-81. PubMed ID: 25064609
[TBL] [Abstract][Full Text] [Related]
14. Desmoid-type fibromatosis in the head and neck: CT and MR imaging characteristics.
Rhim JH; Kim JH; Moon KC; Park SW; Sohn CH; Choi SH; Yun TJ; Chang KH
Neuroradiology; 2013 Feb; 55(3):351-9. PubMed ID: 23338838
[TBL] [Abstract][Full Text] [Related]
15. MRI T1 Contrast-Enhanced Signal Intensity Is a Prognostic Indicator of Imatinib Therapy in Desmoid-Type Fibromatosis.
Zhu HC; Xu SX; Li XT; Guan Z; Li S; Sun YS
Front Oncol; 2021; 11():615986. PubMed ID: 33854962
[TBL] [Abstract][Full Text] [Related]
16. MRI characteristics predict the efficacy of meloxicam treatment in patients with desmoid-type fibromatosis.
Shimizu K; Hamada S; Sakai T; Ito S; Urakawa H; Arai E; Ikuta K; Koike H; Ishiguro N; Nishida Y
J Med Imaging Radiat Oncol; 2019 Dec; 63(6):751-757. PubMed ID: 31448875
[TBL] [Abstract][Full Text] [Related]
17. MRI diagnosis and follow-up of chest wall and breast desmoid tumours in patients with a history of oncologic breast surgery and silicone implants: A pictorial report.
Grubstein A; Rapson Y; Zer A; Gadiel I; Atar E; Morgenstern S; Gutman H
J Med Imaging Radiat Oncol; 2019 Feb; 63(1):47-53. PubMed ID: 30443994
[TBL] [Abstract][Full Text] [Related]
18. MRI and scintigraphic features of extraabdominal desmoid tumors.
Kobayashi H; Kotoura Y; Hosono M; Tsuboyama T; Sakahara H; Endo K; Konishi J
Clin Imaging; 1997; 21(1):35-9. PubMed ID: 9117929
[TBL] [Abstract][Full Text] [Related]
19. MRI may be used as a prognostic indicator in patients with extra-abdominal desmoid tumours.
Kamali F; Wang WL; Guadagnolo BA; Fox PS; Lewis VO; Lazar AJ; Conley AP; Ravi V; Toliyat M; Ladha HS; Hobbs BP; Amini B
Br J Radiol; 2016; 89(1058):20150308. PubMed ID: 26577289
[TBL] [Abstract][Full Text] [Related]
20. Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis.
Fiore M; Colombo C; Radaelli S; Callegaro D; Palassini E; Barisella M; Morosi C; Baldi GG; Stacchiotti S; Casali PG; Gronchi A
Eur J Cancer; 2015 Dec; 51(18):2800-7. PubMed ID: 26602014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]